Does Rallies show 13F holders for APYX?

Yes. Rallies tracks hedge fund and 13F ownership data for APYX, including fund names, share counts, latest tracked quarter, and position changes when available.

Is APYX research on Rallies investment advice?

No. Rallies provides research, data, and educational context for APYX. It does not provide personalized investment advice.

APYX (Apyx Medical Corporation Common Stock) Stock Analysis - Hedge Fund Holdings

Apyx Medical Corporation Common Stock (APYX) is a publicly traded Healthcare sector company. As of May 21, 2026, APYX trades at $3.79 with a market cap of $162.05M and a P/E ratio of -14.02. APYX moved -4.57% today. Year to date, APYX is +7.06%; over the trailing twelve months it is +154.36%. Its 52-week range spans $0.76 to $4.50. Analyst consensus is strong buy with an average price target of $6.00. Rallies surfaces APYX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns APYX stock?

Hedge funds tracked by Rallies that own APYX include Exoduspoint Capital. The latest tracked quarter is Dec 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Apyx Medical Corporation Common Stock.

APYX Key Metrics

Key financial metrics for APYX
Metric	Value
Price	$3.79
Market Cap	$162.05M
P/E Ratio	-14.02
EPS	$-0.27
Dividend Yield	0.00%
52-Week High	$4.50
52-Week Low	$0.76
Volume	0
Avg Volume	0
Revenue (TTM)	$52.84M
Net Income	$-11.11M
Gross Margin	62.53%

Top Hedge Funds Holding APYX

Exoduspoint Capital holds 87.11K shares of APYX, changed +0.00% as of Dec 31, 2025.

Latest APYX News

Renuvion Combined with Liposuction Yields 50% Fewer Abdominoplasties, Higher Body-Q — May 14, 2026
Apyx Secures FDA Clearance for AYON System Power Liposuction Feature — May 11, 2026
Apyx’s Renuvion Wins NewBeauty Award and Shows Q1 Margin Improvement — May 7, 2026
Apyx Medical raises FY2026 revenue guidance after 32% Q1 sales jump — May 7, 2026

Recent APYX Insider Trades

HILL MATTHEW C bought 6.00K (~$6.78K) on Aug 13, 2024.
HILL MATTHEW C bought 5.34K (~$6.03K) on Aug 13, 2024.
HILL MATTHEW C bought 2.50K (~$5.47K) on Dec 12, 2023.

APYX Analyst Consensus

3 analysts cover APYX: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $6.00.

Common questions about APYX

Who owns APYX stock?: Hedge funds tracked by Rallies that own APYX include Exoduspoint Capital. The latest tracked quarter is Dec 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Apyx Medical Corporation Common Stock.
Does Rallies show 13F holders for APYX?: Yes. Rallies tracks hedge fund and 13F ownership data for APYX, including fund names, share counts, latest tracked quarter, and position changes when available.
Is APYX research on Rallies investment advice?: No. Rallies provides research, data, and educational context for APYX. It does not provide personalized investment advice.